The Management of Type 2 Diabetic Patients with Hypoglycemic Agents

Aims and Scope. Aims of the paper are to suggest the best treatment to improve the glycemic control in patients with Type 2 diabetes using hypoglycemic agents, in particularly, we think that every patient is different from another one in terms of BMI, family history, duration of the disease and so o...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnevale Schianca, G. P., Sola, D., Rossi, L., Fra, G. P., Bartoli, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335186/
https://www.ncbi.nlm.nih.gov/pubmed/22577575
http://dx.doi.org/10.5402/2012/601380
_version_ 1782230762922180608
author Carnevale Schianca, G. P.
Sola, D.
Rossi, L.
Fra, G. P.
Bartoli, E.
author_facet Carnevale Schianca, G. P.
Sola, D.
Rossi, L.
Fra, G. P.
Bartoli, E.
author_sort Carnevale Schianca, G. P.
collection PubMed
description Aims and Scope. Aims of the paper are to suggest the best treatment to improve the glycemic control in patients with Type 2 diabetes using hypoglycemic agents, in particularly, we think that every patient is different from another one in terms of BMI, family history, duration of the disease and so on. We propose for every clinical aspect the best hypoglycemic agents to use, considering the scientific evidence and physiopathology.
format Online
Article
Text
id pubmed-3335186
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-33351862012-05-10 The Management of Type 2 Diabetic Patients with Hypoglycemic Agents Carnevale Schianca, G. P. Sola, D. Rossi, L. Fra, G. P. Bartoli, E. ISRN Endocrinol Review Article Aims and Scope. Aims of the paper are to suggest the best treatment to improve the glycemic control in patients with Type 2 diabetes using hypoglycemic agents, in particularly, we think that every patient is different from another one in terms of BMI, family history, duration of the disease and so on. We propose for every clinical aspect the best hypoglycemic agents to use, considering the scientific evidence and physiopathology. International Scholarly Research Network 2012-04-04 /pmc/articles/PMC3335186/ /pubmed/22577575 http://dx.doi.org/10.5402/2012/601380 Text en Copyright © 2012 G. P. Carnevale Schianca et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Carnevale Schianca, G. P.
Sola, D.
Rossi, L.
Fra, G. P.
Bartoli, E.
The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
title The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
title_full The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
title_fullStr The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
title_full_unstemmed The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
title_short The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
title_sort management of type 2 diabetic patients with hypoglycemic agents
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335186/
https://www.ncbi.nlm.nih.gov/pubmed/22577575
http://dx.doi.org/10.5402/2012/601380
work_keys_str_mv AT carnevaleschiancagp themanagementoftype2diabeticpatientswithhypoglycemicagents
AT solad themanagementoftype2diabeticpatientswithhypoglycemicagents
AT rossil themanagementoftype2diabeticpatientswithhypoglycemicagents
AT fragp themanagementoftype2diabeticpatientswithhypoglycemicagents
AT bartolie themanagementoftype2diabeticpatientswithhypoglycemicagents
AT carnevaleschiancagp managementoftype2diabeticpatientswithhypoglycemicagents
AT solad managementoftype2diabeticpatientswithhypoglycemicagents
AT rossil managementoftype2diabeticpatientswithhypoglycemicagents
AT fragp managementoftype2diabeticpatientswithhypoglycemicagents
AT bartolie managementoftype2diabeticpatientswithhypoglycemicagents

Ejemplares similares